Abstract
As the COVID-19 pandemic continues to ravage the world and threaten people's lives, treating infected patients effectively has been one of the top concerns for medical workers around the world. Currently, no medication is recommended to treat COVID-19, and no cure is available. Researchers are testing a variety of possible treatments. Several drugs are being researched in different countries. Most are existing drugs that are being trialled against the virus. Pharmaceuticals undergoing clinical trials to assess their safety and efficacy as potential treatments for COVID-19, include the antiviral nucleotide analogue remdesivir, systemic interferons and in particular interferon β-1a, the antiviral combination lopinavir/ritonavir, the antimalarial chloroquine/hydroxychloroquine, and monoclonal antibodies against components of the immune system such as interleukin-6 (IL-6) and IL-4. It is important that the potential treatments are carefully assessed in randomised controlled trials..
Reference63 articles.
1. Amanat F, Krammer F. SARS-CoV-2 vaccines: status report. Immunity, 2020; 52(4), 583-589. https://doi.org/10.1016/j.immuni. 2020.03.007
2. Khan N, Fahad S. Critical review of the present situation of corona virus in China. Available at SSRN. 2020; 3543177.
3. Memberships M, Join T. Guidance on Coronavirus Disease 2019 (COVID-19) for Transplant Clinicians Updated 27 February 2020.
4. World Health Organization (a). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Retrieved March 28, 2020 from https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
5. Matthay MA, Aldrich JM, Gotts JE. Treatment for severe acute respiratory distress syndrome from COVID-19. Lancet Respir Med 2020. DOI: 10.1016/S2213-2600(20)30127-2. 18.